Cantor Fitzgerald Weighs in on Tourmaline Bio FY2026 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Tourmaline Bio in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer expects that the company will earn ($2.91) per share for the year. The consensus estimate for Tourmaline Bio’s current […]
